David Shaw’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75M Buy
91,415
+18,344
+25% +$319K ﹤0.01% 3315
2026
Q1
$1.16M Sell
73,071
-143
-0.2% -$2.5K ﹤0.01% 3340
2025
Q4
$1.3M Buy
73,214
+61,123
+506% +$1.07M ﹤0.01% 3365
2025
Q3
$224K Buy
+12,091
New +$249K ﹤0.01% 4239
2024
Q2
Sell
-22,928
Closed -$669K 4666
2024
Q1
$669K Buy
+22,928
New +$641K ﹤0.01% 3330
2023
Q4
Sell
-8,345
Closed -$267K 4450
2023
Q3
$267K Sell
8,345
-14,677
-64% -$565K ﹤0.01% 3665
2023
Q2
$1.01M Buy
23,022
+6,641
+41% +$306K ﹤0.01% 3084
2023
Q1
$726K Buy
+16,381
New +$724K ﹤0.01% 3363
2022
Q1
Sell
-8,521
Closed -$510K 5754
2021
Q4
$510K Buy
8,521
+4,932
+137% +$307K ﹤0.01% 4389
2021
Q3
$235K Buy
+3,589
New +$233K ﹤0.01% 4493
2020
Q3
Sell
-5,032
Closed -$220K 3990
2020
Q2
$220K Sell
5,032
-2,710
-35% -$122K ﹤0.01% 3742
2020
Q1
$307K Sell
7,742
-5,324
-41% -$239K ﹤0.01% 3457
2019
Q4
$614K Buy
13,066
+7,321
+127% +$284K ﹤0.01% 3284
2019
Q3
$203K Sell
5,745
-26,805
-82% -$929K ﹤0.01% 3621
2019
Q2
$1.27M Sell
32,550
-12,283
-27% -$495K ﹤0.01% 2533
2019
Q1
$1.98M Buy
44,833
+32,799
+273% +$1.25M ﹤0.01% 2165
2018
Q4
$420K Sell
12,034
-2,736
-19% -$86.7K ﹤0.01% 3187
2018
Q3
$541K Sell
14,770
-6,370
-30% -$195K ﹤0.01% 3063
2018
Q2
$563K Buy
21,140
+5,159
+32% +$110K ﹤0.01% 3048
2018
Q1
$241K Sell
15,981
-5,848
-27% -$104K ﹤0.01% 3246
2017
Q4
$419K Buy
+21,829
New +$418K ﹤0.01% 3082

Other funds holding KIDS

David Shaw's KIDS Position: Q2 2026 in Review

David Shaw increased its OrthoPediatrics (KIDS) stake by 25% in Q2 2026, buying an estimated $319K and bringing the position to 91,415 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #3315.

David Shaw first reported a position in KIDS in Q4 2017 and has held it in 21 quarters since. The position peaked at $1.98M in Q1 2019. 119 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.

  • David Shaw held 91,415 shares of OrthoPediatrics worth $1.75M as of Q2 2026.
  • David Shaw bought 18,344 OrthoPediatrics shares in Q2 2026, an estimated $319K.
  • OrthoPediatrics made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3315 holding.
  • David Shaw first reported a position in OrthoPediatrics in Q4 2017 and has held it in 21 quarters since.
  • David Shaw's OrthoPediatrics position peaked at $1.98M in Q1 2019.
  • 119 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.